Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 21, 2024

Ticagrelor Alone vs Ticagrelor Plus Aspirin From 1 Month to 1 Year After PCI in Patients With Acute Coronary Syndromes

The Lancet


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
Lancet 2024 Apr 05;[EPub Ahead of Print], Z Ge, J Kan, X Gao, A Raza, JJ Zhang, BS Mohydin, F Gao, Y Shao, Y Wang, H Zeng, F Li, HS Khan, N Mengal, H Cong, M Wang, L Chen, Y Wei, F Chen, GW Stone, SL Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading